Shares of Greenfire Resources Ltd (NYSE:GFR) rose sharply in pre-market trading after Strathcona Resources announced plans to acquire the company in a C$2.7 billion-C$2.9 billion deal, including C$550 million net debt.

Greenfire Resources shares jumped 25.3% to $7.02 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

• CL Workshop Group Ltd – ADR (NASDAQ:NWGL) rose 133.6% to $5.91 in pre-market trading. The company recently announced it will change the ratio of its ADS from 1 ADS representing 8 shares to 1 representing 640 shares.
• JIADE Ltd (NASDAQ:JDZG) gained 132.7% to $0.49 in pre-market trading after dipping over 46% on Friday.
• Ohmyhome Ltd (NASDAQ:OMH) jumped 98.4% to $14.60 in pre-market trading after falling around 45% on Friday.
• Generation Essentials Group (NYSE:TGE) gained 43.7% to $0.52 in pre-market trading.
• NetClass Technology Inc (NASDAQ:NTCL) gained 37.2% to $0.31 in pre-market trading. Univest Securities, LLC announced closing of $1.2 million registered direct offering for its client NetClass Technology.
• J-Star Holding Co Ltd (NASDAQ:YMAT) gained 24.7% to $1.31 in pre-market trading after declining 4% on Friday.
• Vir Biotechnology Inc (NASDAQ:VIR) rose 14.6% to $13.98 in pre-market trading. Vir’s Elebsiran and Tobevibart met primary endpoint in Phase 3 ECLIPSE 1 hepatitis delta trial.
• INLIF Ltd (NASDAQ:INLF) gained 13.2% to $0.26 in pre-market trading after falling over 6% on Friday.
• Faeth Therapeutics, Inc. (NASDAQ:FTH) gained 9% to $24.04 in pre-market trading. Faeth will report PIK-201 Phase 2 data and host virtual event on Nov. 9.

Losers

• Plutus Financial Group Ltd (NASDAQ:PLUT) fell 23.5% to $0.84 in pre-market trading after declining over 10% on Friday.
• Karyopharm Therapeutics Inc (NASDAQ:KPTI) fell 21.7% to $0.043 in pre-market trading after declining over 8% on Friday. Karyopharm Therapeutics, last week, announced it will be delisted from the Nasdaq.
• CDT Equity Inc (NASDAQ:CDT) fell 18.4% to $1.07 in pre-market trading. CDT Equity shares gained around 14% on Friday after the company disclosed that Corvus intends to make a proposal to acquire the entire issued share capital of CDT Equity for $2.00 per share.
• SunCar Technology Group Inc. (NASDAQ:SDA) fell 13.8% to $0.3247 in pre-market trading. SunCar Technology shares surged 144% on Friday after the company forecast 26% nine-month revenue growth, a return to profitability, and announced a $10 million share repurchase program.
• Onconetix, Inc. (NASDAQ:ONCO) tumbled 13.7% to $6.00 in pre-market trading. Onconetix shares jumped over 26% on Friday after the company amended its proposed Realbotix share exchange, extending the deal deadline to March 2027 and revising the transaction terms..
• RedCloud Holdings plc (NASDAQ:RCT) fell 12.3% to $0.0372 in pre-market trading. RedCloud shares climbed 41% on Friday after the London-based technology and B2B open commerce platform announced a new integration agreement in Argentina.
• Pluri Inc. (NASDAQ:PLUR) shares declined 11% to $1.10 in pre-market trading. Pluri recently announced a definitive strategic agreement with ZEO ScientifiX to expand the parties’ U.S. manufacturing and commercialization platform serving the regenerative medicine, aesthetics, wellness, and longevity markets.
• Tianci International, Inc. (NASDAQ:CIIT) fell 10% to $2.16 in pre-market trading after jumping 55% on Friday. The company said revenue for the year ended July 31 climbed to $14.24 million from $9.28 million a year earlier.
• CEVA, Inc. (NASDAQ:CEVA) declined 6.7% to $25.28 in pre-market trading after gaining 10% on Friday.
• Cypherpunk Technologies Inc. (NASDAQ:CYPH) declined 6.6% to $2.69 in pre-market trading after jumping around 16% on Friday.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.